Method for maintaining and amplifying human primordial germ cells/human primordial germ cell-like cells
Provided are: a method for maintaining and amplifying human primordial germ cells (hPGC) or human primordial germ cell-like cells (hPGCLC) derived from human pluripotent stem cells; the method includes culturing hPGCLC in the presence of (i) forskolin or a phosphodiesterase 4 (PDE4) inhibitor, and (...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
23.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided are: a method for maintaining and amplifying human primordial germ cells (hPGC) or human primordial germ cell-like cells (hPGCLC) derived from human pluripotent stem cells; the method includes culturing hPGCLC in the presence of (i) forskolin or a phosphodiesterase 4 (PDE4) inhibitor, and (ii) one or more cytokines selected from the group consisting of basic fibroblast proliferation factor (bFGF), leukemia inhibitory factor (LIF), and epithelial growth factor (EGF).
本发明提供:人原始生殖细胞(hPGC)或来自人多能干细胞的人原始生殖细胞样细胞(hPGCLC)的维持扩增方法,该方法包括:在(i)佛司可林或磷酸二酯酶4(PDE4)抑制剂、以及(ii)选自碱性成纤维细胞增殖因子(bFGF)、白血病抑制因子(LIF)和上皮生长因子(EGF)的1种以上的细胞因子的存在下培养hPGCLC。 |
---|---|
Bibliography: | Application Number: CN20218050606 |